Healthcare - Biotechnology - NASDAQ - GB
$ 2.08
-7.56 %
$ 25.3 M
Market Cap
-0.7
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
41.42%
Net Income
Estimate
41.42%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Akari Therapeutics, Plc
AKTX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart AKTX
EBIT FORECAST
EBIT Forecast Chart AKTX
NET INCOME FORECAST
Net Income Chart AKTX